FAKTOR OPTIONSSCHEIN - MEDTRONIC Stock

Certificat

DE000UL9MZW7

Market Closed - Deutsche Boerse AG 01:26:10 2024-05-24 pm EDT
2.11 EUR +1.44% Intraday chart for FAKTOR OPTIONSSCHEIN - MEDTRONIC
Current month-10.59%
1 month-11.34%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-24 2.11 +1.44%
24-05-23 2.08 +15.56%
24-05-22 1.8 -3.23%
24-05-21 1.86 -0.53%
24-05-20 1.87 +4.47%

Delayed Quote Deutsche Boerse AG

Last update May 24, 2024 at 01:26 pm EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying MEDTRONIC PLC
Issuer UBS
WKN UL9MZW
ISINDE000UL9MZW7
Date issued 2023-11-01
Strike 101.7 $
Maturity Unlimited
Parity 8.55 : 1
Emission price 5.01
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5.05
Lowest since issue 1.68
Spread 0.05
Spread %2.35%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
82.29 USD
Average target price
94.74 USD
Spread / Average Target
+15.13%
Consensus